Peter A Kiener Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter A Kiener.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A Kiener. Peter A Kiener is Chief Science Officer in Sucampo Pharmaceuticals, Inc. ($SCMP) and Chief Scientific Officer in Sucampo Pharmaceuticals, Inc. ($SCMP) and in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Cue Biopharma, Inc. ($CUE).
Latest Insider Trading Transactions of Peter A Kiener
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CUE, PIRS, SCMP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | CUE | Cue Biopharma, Inc ... | Kiener Peter A | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
| Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
| Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
| Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.23 | 20,000 | 64,600 | 20,000 | ||
| Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
| Oct 25 2018 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 4.46 | 30,000 | 133,800 | 30,000 | ||
| Jun 14 2018 | CUE | Cue Biopharma, Inc ... | Kiener Peter A | Director | Option Exercise | M | 14.24 | 9,600 | 136,704 | 9,600 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | D | 11.85 | 133,000 | 1,576,050 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | D | 13.80 | 87,203 | 1,203,401 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | D | 14.82 | 38,500 | 570,570 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | D | 8.33 | 250,000 | 2,082,500 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Sell | D | 18.00 | 44,856 | 807,408 | 0 | 44.9 K to 0 (-100.00 %) |
| Jan 04 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Grant | A | 9.10 | 329 | 2,994 | 44,856 | 44.5 K to 44.9 K (+0.74 %) |
| Jan 02 2018 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Payment of Exercise | F | 17.98 | 27,496 | 494,378 | 44,527 | 72 K to 44.5 K (-38.18 %) |
| Dec 11 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Option Exercise | M | 8.33 | 50,000 | 416,500 | 242,567 | |
| Dec 11 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Sell | S | 16.50 | 50,000 | 825,000 | 2,023 | 52 K to 2 K (-96.11 %) |
| Dec 11 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Buy | M | 8.33 | 50,000 | 416,500 | 52,023 | 2 K to 52 K (+2,471.58 %) |
| Oct 05 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Grant | A | 9.10 | 330 | 3,003 | 2,023 | 1.7 K to 2 K (+19.49 %) |
| Jul 07 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Grant | A | 8.93 | 336 | 3,000 | 1,693 | 1.4 K to 1.7 K (+24.76 %) |
| May 10 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Science Offic ... | Grant | A | 9.35 | 321 | 3,001 | 1,357 | 1 K to 1.4 K (+30.98 %) |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Option Exercise | A | 11.85 | 133,000 | 1,576,050 | 626,270 | |
| Mar 08 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 0.00 | 70,000 | 0 | 70,000 | 0 to 70 K |
| Jan 06 2017 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 10.46 | 287 | 3,002 | 1,036 | 749 to 1 K (+38.32 %) |
| Oct 21 2016 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 9.38 | 320 | 3,002 | 749 | 429 to 749 (+74.59 %) |
| Jul 18 2016 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 9.32 | 300 | 2,796 | 429 | 129 to 429 (+232.56 %) |
| Jun 16 2016 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Grant | A | 9.29 | 129 | 1,198 | 129 | 0 to 129 |
| Mar 04 2016 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Option Exercise | A | 13.80 | 116,270 | 1,604,526 | 493,270 | |
| Mar 13 2015 | SCMP | Sucampo Pharmaceut ... | Kiener Peter A | Chief Scientific Of ... | Option Exercise | A | 14.82 | 77,000 | 1,141,140 | 377,000 |
Page: 1